| Product Code: ETC7636812 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of paracetamol IV into Ireland saw significant growth in 2024, with top exporting countries being Germany, UK, USA, Canada, and other areas. The market concentration, as measured by HHI, shifted from moderate to high in 2024, indicating increased dominance by key players. The impressive Compound Annual Growth Rate (CAGR) of 23.25% from 2020 to 2024 highlights the robust expansion of the market. Moreover, the remarkable growth rate of 68.68% from 2023 to 2024 signifies a rapid acceleration in demand for paracetamol IV in Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Paracetamol IV Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Paracetamol IV Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Paracetamol IV Market - Industry Life Cycle |
3.4 Ireland Paracetamol IV Market - Porter's Five Forces |
3.5 Ireland Paracetamol IV Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Ireland Paracetamol IV Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Paracetamol IV Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Ireland Paracetamol IV Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of acute and chronic pain conditions requiring intravenous pain management |
4.2.2 Growing demand for efficient and quick pain relief solutions in healthcare settings |
4.2.3 Technological advancements in drug delivery systems enhancing the efficacy of intravenous paracetamol |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for manufacturing and distribution of intravenous medications |
4.3.2 Potential side effects and safety concerns associated with intravenous administration of paracetamol |
5 Ireland Paracetamol IV Market Trends |
6 Ireland Paracetamol IV Market, By Types |
6.1 Ireland Paracetamol IV Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Ireland Paracetamol IV Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Ireland Paracetamol IV Market Revenues & Volume, By Pain, 2021- 2031F |
6.1.4 Ireland Paracetamol IV Market Revenues & Volume, By Pyrexia (Fever), 2021- 2031F |
6.2 Ireland Paracetamol IV Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Paracetamol IV Market Revenues & Volume, By Surgical, 2021- 2031F |
6.2.3 Ireland Paracetamol IV Market Revenues & Volume, By Non-surgical, 2021- 2031F |
6.3 Ireland Paracetamol IV Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Ireland Paracetamol IV Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Ireland Paracetamol IV Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Ireland Paracetamol IV Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Paracetamol IV Market Import-Export Trade Statistics |
7.1 Ireland Paracetamol IV Market Export to Major Countries |
7.2 Ireland Paracetamol IV Market Imports from Major Countries |
8 Ireland Paracetamol IV Market Key Performance Indicators |
8.1 Average length of hospital stay for patients receiving intravenous paracetamol |
8.2 Number of healthcare facilities adopting intravenous paracetamol as a preferred pain management option |
8.3 Rate of patient satisfaction with intravenous paracetamol therapy |
9 Ireland Paracetamol IV Market - Opportunity Assessment |
9.1 Ireland Paracetamol IV Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Ireland Paracetamol IV Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Paracetamol IV Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Ireland Paracetamol IV Market - Competitive Landscape |
10.1 Ireland Paracetamol IV Market Revenue Share, By Companies, 2024 |
10.2 Ireland Paracetamol IV Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |